These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21304090)

  • 21. [HLA-incompatibility and kidney transplant: a question of desensitization].
    Grosjean F
    G Ital Nefrol; 2011; 28(6):581. PubMed ID: 22167608
    [No Abstract]   [Full Text] [Related]  

  • 22. More questions than answers: Current limitations of kidney transplantation treatment.
    Spechtl P; Oberbauer R
    Eur J Clin Invest; 2021 May; 51(5):e13513. PubMed ID: 33577079
    [No Abstract]   [Full Text] [Related]  

  • 23. [Kidney transplantation for therapy of late-stage kidney failure].
    Sakai K; Hasegawa A
    Nihon Naika Gakkai Zasshi; 1998 Jul; 87(7):1335-40. PubMed ID: 9745285
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of immunosuppression on the renal transplant patient.
    Keck BH; Reams DR
    Nephrol Nurse; 1981; 3(6):10-1. PubMed ID: 7029323
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal homotransplantation in childhood: with special reference to the infant recipient and the lymphocyte chalone.
    Lilly JR; Anderson KD; Altman RP; Randolph JG
    Mil Med; 1975 Sep; 140(9):626-9. PubMed ID: 125859
    [No Abstract]   [Full Text] [Related]  

  • 26. Current state of renal transplantation in India.
    Reddy YN; Abraham G; Pavanathan A; Roy-Chaudhury P
    J Indian Med Assoc; 2013 Aug; 111(8):518-20, 522-3. PubMed ID: 24783389
    [No Abstract]   [Full Text] [Related]  

  • 27. De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation.
    Koch M; Wiech T; Marget M; Peine S; Thude H; Achilles EG; Fischer L; Lehnhardt A; Thaiss F; Nashan B
    Clin Transplant; 2015 Nov; 29(11):1021-8. PubMed ID: 26333844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful living donor kidney transplantation across HLA and ABO incompatibilities.
    Magee CC; Mah H; Tinckam K; Wood I; Ji F; Powelson J
    Nephrol Dial Transplant; 2007 Feb; 22(2):602-4. PubMed ID: 17132704
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal transplantation for ADPKD patients: a 2007 update.
    Bennett WM
    Nephrol News Issues; 2007 Mar; 21(4):24-5, 27. PubMed ID: 17393922
    [No Abstract]   [Full Text] [Related]  

  • 30. Kidney Transplantation: The Beauty and the Beast!
    Breda A
    Eur Urol Focus; 2018 Mar; 4(2):139. PubMed ID: 30061074
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results of the kidney transplantation program of the first Internal Medicine Clinic of the Vienna University].
    Schmidt P; Zazgornik J; Kopsa H; Kotzaurek R; Deutsch E
    Wien Klin Wochenschr; 1973 Jun; 85(25):450-5. PubMed ID: 4576351
    [No Abstract]   [Full Text] [Related]  

  • 32. Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation.
    Gill JS; Tonelli M
    N Engl J Med; 2012 Feb; 366(7):586-9. PubMed ID: 22296029
    [No Abstract]   [Full Text] [Related]  

  • 33. Kidney transplantation from living related donors.
    Mouquet C; Benalia H; Barrou B; Ourahma S; Luciani J; Coriat P; Bitker MO
    Transplant Proc; 1996 Oct; 28(5):2801. PubMed ID: 8908065
    [No Abstract]   [Full Text] [Related]  

  • 34. High risk of obstructive sleep apnea is a risk factor of death censored graft loss in kidney transplant recipients: an observational cohort study.
    Szentkiralyi A; Czira ME; Molnar MZ; Kovesdy CP; Remport A; Szeifert L; Vamos EP; Juhasz J; Turanyi CZ; Mucsi I; Novak M
    Sleep Med; 2011 Mar; 12(3):267-73. PubMed ID: 21292552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rescue splenectomy for severe acute antibody-mediated rejection.
    Locke JE; Zachary AA; Mohammed BS; Warren DS; Montgomery RA
    Clin Transpl; 2006; ():518-20. PubMed ID: 18365416
    [No Abstract]   [Full Text] [Related]  

  • 36. "Early" withdrawal of glucocorticosteroids is well tolerated by kidney transplant recipients without increasing allograft rejection while preserving bone integrity.
    Friedman EA
    Transplantation; 2014 Dec; 98(12):1255-6. PubMed ID: 25136846
    [No Abstract]   [Full Text] [Related]  

  • 37. Postoperative cardiac tamponade after kidney transplantation: a possible consequence of alemtuzumab-induced cytokine release syndrome.
    Adams PS; Shapiro R; Hilmi IA
    Transplantation; 2013 Feb; 95(3):e18-9. PubMed ID: 23380870
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunosuppression after renal allograft failure: a survey of US practices.
    Bayliss GP; Gohh RY; Morrissey PE; Rodrigue JR; Mandelbrot DA
    Clin Transplant; 2013; 27(6):895-900. PubMed ID: 24118389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction: Kidney Transplantation and Viral Infection.
    Brennan DC
    Semin Nephrol; 2016 Sep; 36(5):343. PubMed ID: 27772618
    [No Abstract]   [Full Text] [Related]  

  • 40. Pregnancy in renal transplant recipients.
    Hou S
    Adv Ren Replace Ther; 2003 Jan; 10(1):40-7. PubMed ID: 12616462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.